Want to see AU:SHL full AI Analyst Report?
SHL Stock Chart & Stats
AU$20.56
-AU$0.19(-0.67%)
At close: 4:00 PM EST
AU$20.56
-AU$0.19(-0.67%)
Day’s Range― - ―
52-Week RangeAU$18.26 - AU$29.24
Previous CloseN/A
Volume607.50K
Average Volume (3M)1.62M
Market Cap
AU$10.28B
Enterprise ValueAU$17.14B
Total Cash (Recent Filing)AU$557.12M
Total Debt (Recent Filing)AU$7.34B
Price to Earnings (P/E)18.7
Beta0.72
Next Earnings
Aug 20, 2026EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)1.11
Shares Outstanding494,237,950
10 Day Avg. Volume1,694,025
30 Day Avg. Volume1,619,425
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.55
Price to Sales (P/S)1.34
P/FCF Ratio13.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$22.11Price Target Upside7.52% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.3
Revenue Forecast (FY)AU$11.30B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSonic's strong free cash flow growth and high operating-cash conversion provide durable internal funding for maintenance capex, acquisitions and the progressive dividend policy. Reliable cash generation supports balance-sheet repair, opportunistic buybacks and funding automation/hub lab investments without solely relying on new equity.
Diversified Organic GrowthConsistent ~5% organic growth across multiple regions and service lines (notably Australia, Germany, UK and radiology) reflects diversified demand drivers. This geographic and product mix diversification reduces revenue concentration risk and supports stable utilization of centralized labs and imaging networks over the medium term.
Margin Expansion & ProductivitySonic is extracting operating leverage via platform procurement, new hub labs and automation, delivering sustained margin improvement. Combined with integration synergies from recent acquisitions and growing digital pathology volume, these structural efficiency gains can underpin incremental EBITDA margin durability even with cyclical volume shifts.
Bears Say
U.S. Margin PressureThe U.S. business faces structural margin headwinds from low organic growth in key segments and ongoing anatomical pathology rationalisation. Restructuring and lower-margin legacy contracts will compress near-term returns and require time to realize synergies, weighing on group profit conversion until actions complete.
Higher Leverage From Deals & PropertyAcquisitions and property investments have raised net debt and leverage, reducing financial flexibility versus prior levels. Higher debt increases interest exposure (management flagged ~15% higher interest) and limits optionality for further M&A or large buybacks absent stronger cash conversion or asset sales.
Working-capital / Collections DisruptionThe Change Healthcare breach materially disrupted billing and collections, inflating receivables and creating temporary vendor advances. Delayed collection improvements push working-capital relief into the next fiscal year, tying up cash and increasing reported net debt until normalised collections resume.
Sonic Healthcare Limited News
SHL FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest share price was AU$18.26 and its highest was AU$29.24 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is AU$10.28B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 50 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported AU$0.5 earnings per share for the quarter, missing the consensus estimate of AU$0.527 by -AU$0.027.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of AU$0.45 which represents an annual dividend yield of 4.69%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.68.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of AU$0.5 in its last earnings report, missing expectations of AU$0.527. Following the earnings report the stock price went up 9.887%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in AU:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$22.11 (7.52% Upside)
AU$22.11 (7.52% Upside)
Blogger Sentiment
Bullish
AU:SHL Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.99%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
10.74%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
SHL Stock 12 Month Forecast
Average Price Target
AU$22.11
▲(7.52% Upside)
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---









